Open questions in oesophageal adenocarcinogenesis.
作者信息
Maley Carlo C
机构信息
Molecular and Cellular Oncogenesis Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.
出版信息
Gut. 2007 Jul;56(7):897-8. doi: 10.1136/gut.2006.117135.
Abstract
Transition from GORD to Barrett's oesophagus, and possibility of a reversal mechanism
摘要
相似文献
1
Open questions in oesophageal adenocarcinogenesis.
Gut. 2007 Jul;56(7):897-8. doi: 10.1136/gut.2006.117135.
2
Reflux, Barrett's esophagus and esophageal adenocarcinoma.
Scand J Gastroenterol. 2014 Dec;49(12):1499-500. doi: 10.3109/00365521.2014.946079. Epub 2014 Aug 6.
3
[Barrett's esophagus and primary adenocarcinoma of the esophagus].
Rev Esp Enferm Apar Dig. 1981 May;59(5):617-26.
4
Should patients with GERD be screened once at least for Barrett's epithelium? Con: Patients with GERD should be screened once at least for Barrett's esophagus--medicine or magic?
Am J Gastroenterol. 2004 Dec;99(12):2293-5. doi: 10.1111/j.1572-0241.2004.41295_2.x.
5
Should patients with GERD be screened once at least for Barrett's epithelium? A balancing view: To screen or not to screen: scoping out the issues.
Am J Gastroenterol. 2004 Dec;99(12):2295-6. doi: 10.1111/j.1572-0241.2004.41295_3.x.
6
Gastroesophageal reflux disease: From heartburn to cancer.
World J Gastroenterol. 2010 Aug 14;16(30):3743-4. doi: 10.3748/wjg.v16.i30.3743.
7
Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
Nat Rev Cancer. 2003 Sep;3(9):676-84. doi: 10.1038/nrc1166.
8
Should patients with GERD be screened once at least for Barrett's epithelium? Pro: The need to screen GERD patients for Barrett's esophagus--a greater yield than surveillance.
Am J Gastroenterol. 2004 Dec;99(12):2291-3. doi: 10.1111/j.1572-0241.2004.41295_1.x.
9
Focus on Barrett's esophagus and esophageal adenocarcinoma.
Cancer Cell. 2004 Jul;6(1):11-6. doi: 10.1016/j.ccr.2004.06.021.
10
The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.
Med Clin North Am. 2016 Sep;100(5):1057-64. doi: 10.1016/j.mcna.2016.04.014.
引用本文的文献
1
Barrett esophagus: history, definition and etiopathogeny.
J Med Life. 2014;7 Spec No. 3(Spec Iss 3):23-30.
2
Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Tumour Biol. 2014 Mar;35(3):2063-8. doi: 10.1007/s13277-013-1273-2. Epub 2013 Nov 10.
本文引用的文献
1
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
PLoS Med. 2007 Feb;4(2):e67. doi: 10.1371/journal.pmed.0040067.
2
Retinoic acid-induced glandular differentiation of the oesophagus.
Gut. 2007 Jul;56(7):906-17. doi: 10.1136/gut.2006.097915. Epub 2006 Dec 21.
3
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Nat Genet. 2006 Apr;38(4):468-73. doi: 10.1038/ng1768. Epub 2006 Mar 26.
4
Neosquamous epithelium does not typically arise from Barrett's epithelium.
Clin Cancer Res. 2006 Mar 15;12(6):1701-6. doi: 10.1158/1078-0432.CCR-05-1810.
5
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
Lancet Oncol. 2005 Dec;6(12):945-52. doi: 10.1016/S1470-2045(05)70431-9.
6
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Gastrointest Endosc. 2005 Oct;62(4):488-98. doi: 10.1016/j.gie.2005.06.047.
7
On the histogenesis of Barrett's oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts.
J Pathol. 2005 Aug;206(4):388-94. doi: 10.1002/path.1804.
8
DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
Am J Gastroenterol. 2004 Oct;99(10):1887-94. doi: 10.1111/j.1572-0241.2004.30886.x.
9
A genetic progression model of oral cancer: current evidence and clinical implications.
J Oral Pathol Med. 2004 Jul;33(6):317-22. doi: 10.1111/j.1600-0714.2004.00225.x.
10
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens.
Mod Pathol. 2004 May;17(5):588-96. doi: 10.1038/modpathol.3800088.
Zotero 插件